P521: Impact of pouch leaks on quality of life and symptoms in patients after ileal pouch-anal anastomosis surgeryECCO'24Year: 2024
Authors: Alipouriani, A.(1);Schabl, L.(1);hull, T.(1);Lipman, J.(1);Gorgun, E.(1);Liska, D.(1);valente, M.(1);Steele, S.R.(1);Holubar, S.(1)*;
(1)Cleveland Clinic Foundation- Cleveland- OH- USA, Department of Colon and Rectal Surgery, Cleveland, United States;
P522: Post hoc analysis reveals limited efficacy of induction therapy in ileum only Crohn´s diseaseECCO'24Year: 2024
Authors: Lundin, P.(1)*;Bock, D.(2);Harper, A.R.(3);Strömbeck, A.(1);Beaton, A.(4);Marks, D.J.B.(3);
(1)AstraZeneca Biopharmaceuticals R&D, Early R&I Clinical Development, Gothenburg, Sweden;(2)AstraZeneca Biopharmaceuticals R&D, Early Biometrics and Statistical Innovation, Gothenburg, Sweden;(3)AstraZeneca Biopharmaceuticals R&D, Early R&I Clinical Development, Cambridge, United Kingdom;(4)AstraZeneca Biopharmaceuticals R&D, Clinical Development Immunology, Cambridge, United Kingdom;
P523: The performance indicator of colonic intubation (PICI) in an Irish Inflammatory Bowel Disease (IBD) cohort.ECCO'24Year: 2024
Authors: Jones, F.(1)*;Lavelle, A.(2);McCarthy, F.(3);Patchett, S.(3);Morcos, A.(3);Moloney, M.(3);Cullen, G.(3);Slattery, E.(3);Leyden, J.(4);O@E@ Morain, C.(5);Egan, L.(5);Doherty, G.A.(6);
(1)St. Vincent@E@s University Hospital- Dublin, Gastroenterology, Dublin 3, Ireland;(2)University College Cork, Medicine, Cork, Ireland;(3)National Group Leads for Endoscopy, Health Service Executive, Dublin, Ireland;(4)HSE GI Endoscopy Programme, Health Service Executive, Dublin, Ireland;(5)National Gastroenterology Clinical Programme, Health Service Executive, Dublin, Ireland;(6)St. Vincent@E@s University Hospital, Gastroenterology, Dublin, Ireland;
P524: Etrasimod shows low risk of adverse events following concomitant use with opioids or antidepressants in patients with ulcerative colitisECCO'24Year: 2024
Authors: Afzali, A.(1)*;Regueiro, M.(2);Yarur, A.J.(3);Zabana, Y.(4);Ng, S.C.(5);Menon, S.S.(6);McDonnell, A.(7);Lazin, K.(8);Keating, M.(9);Bhattacharjee, A.(10);Branquinho, D.(9);Bananis, E.(11);Peyrin-Biroulet, L.(12,13,14,15,16,17);
(1)University of Cincinnati College of Medicine, Department of Internal Medicine, Cincinnati- OH, United States;(2)Cleveland Clinic, Department of Gastroenterology- Hepatology and Nutrition, Cleveland- OH, United States;(3)Cedars-Sinai Medical Center, Inflammatory Bowel Disease Center and Division of Gastroenterology and Hepatology, Los Angeles- CA, United States;(4)Hospital Universitari Mútua Terrassa and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Department of Gastroenterology, Madrid, Spain;(5)Institute of Digestive Disease- The Chinese University of Hong Kong, Department of Medicine and Therapeutics, Hong Kong, China;(6)., Pfizer Inc, Groton- CT, United States;(7)., Pfizer Ltd, Sandwich, United Kingdom;(8)., Pfizer AG, Zürich, Switzerland;(9)., Pfizer Inc, New York- NY, United States;(10)., Pfizer Healthcare India Pvt. Ltd, Chennai, India;(11)., Pfizer Inc, Collegeville- PA, United States;(12)Nancy University Hospital, Department of Gastroenterology, F-54500 Vandœuvre-lès-Nancy, France;(13)Nancy University Hospital, Fédération Hospitalo-Universitaire-CURE, F-54500 Vandœuvre-lès-Nancy, France;(14)McGill University Health Centre, Division of Gastroenterology and Hepatology, Montreal- QC, Canada;(15)Paris IBD Center, Groupe Hospitalier privé Ambroise Paré - Hartmann, 92200 Neuilly sur Seine, France;(16)Nancy University Hospital, INFINY Institute, F-54500 Vandœuvre-lès-Nancy, France;(17)University of Lorraine, Inserm- NGERE, F-54000 Nancy, France;
P525: Utilisation of endoscopic ultrasonography for submucosal cushion measurement to determine eligibility for endoscopic submucosal dissection in ulcerative colitis-associated dysplasia: A case seriesECCO'24Year: 2024
Authors: Kim, K.(1)*;Hong, S.W.(2);Hwang, S.W.(2);Park, S.H.(2);Ye, B.D.(2);Byeon, J.S.(2);Myung, S.J.(2);Yang, S.K.(2);Yang, D.H.(2);
(1)Chung-Ang University Hospital, Department of Gastroenterology, Seoul, Korea- Republic Of;(2)University of Ulsan College of Medicine- Asan Medical Center, Department of Gastroenterology, Seoul, Korea- Republic Of;
P526: Handsewn versus Stapled Ileocolic Anastomosis for Crohn@E@s: Comparable Outcomes Despite More Severe Disease Profile in the Handsewn GroupECCO'24Year: 2024
Authors: Alipouriani, A.(1);Uchino, T.(1);Erozkan, K.(1);Lipman , J.(1);Hull, T.(1);Steele, S.R.(1);Holubar, S.(1)*;
(1)Cleveland Clinic Foundation- Cleveland- OH- USA, Department of Colon and Rectal Surgery, Cleveland, United States;
P527: Factors associated with choice of treatment regimen after the induction period in patients with Ulcerative Colitis treated with vedolizumabECCO'24Year: 2024
Authors: Vuksanovic, S.(1)*;Spiric, J.(1);Toplicanin, A.(1);Nikolic, A.(1);Jovicic, I.(1);Djuranovic, S.(1,2);Popovic, D.(1,2);Dragasevic, S.(1,2);Sokic Milutinovic, A.(1,2);
(1)University Clinical Centre of Serbia, Clinic for Gastroenterology and Hepatology, Belgrade, Serbia;(2)University of Belgrade, School of Medicine, Belgrade, Serbia;
P529: Assessing patient-perceived burden of disease in Crohn’s disease: a novel scoring approach in a real-world Australasian cohortECCO'24Year: 2024
Authors: Pipicella, J.L.(1,2,3)*;Gu, B.(1,4);Palmer, L.(5);Connor, S.J.(1,2,3,4);Wilson, W.(6,7);Andrews, J.M.(3,8,9);
(1)University of New South Wales, Medicine & Health South Western Sydney Clinical School, Sydney, Australia;(2)Ingham Institute for Applied Medical Research, Gastroenterology- Hepatology and Inflammatory Bowel Disease Research Group, Liverpool, Australia;(3)Crohn@E@s Colitis Cure, CCCure, Pyrmont, Australia;(4)Liverpool Hospital, Gastroenterology and Hepatology, Liverpool, Australia;(5)The University of Adelaide, School of Public Health- Faculty of Health and Medical Sciences, Adelaide, Australia;(6)Lyell McEwin Hospital, Anaesthetics, Adelaide, Australia;(7)SA Health, Chief Medical Information Officer, Adelaide, Australia;(8)The University of Adelaide, Faculty of Health Sciences, Adelaide, Australia;(9)Central Adelaide Local Health Network, Gastroenterology, Adelaide, Australia;
P530: Early Intestinal Ultrasound changes to predict treatment response to anti-TNF therapy in paediatric Inflammatory Bowel Disease; a pilot studyECCO'24Year: 2024
Authors: Vos, H.(1)*;Gecse, K.(2);D@E@Haens, G.(2);Benninga, M.(1);Koot, B.(1);
(1)Amsterdam University Medical Centers, Paediatric Gastroenterology and Nutrition, Amsterdam, The Netherlands;(2)Amsterdam University Medical Centers, Gastroenterology and Hepatology, Amsterdam, The Netherlands;RAINBOW group
P531: Long-Term Evaluation of Intensified Ustekinumab in Crohn@E@s Disease: Real-Life ResultsECCO'24Year: 2024
Authors: Molina Arriero, G.(1)*;González Furelos, T.(2);Mauriz Barreiro, V.(1);Echarri Piudo, A.(1);
(1)Complejo Hospitalario Universitario de Ferrol, Gastroenterology, Ferrol, Spain;(2)Complejo Hospitalario Universitario de Ferrol, Pharmacology Department, Ferrol, Spain;
P532: The enhanced recovery after surgery protocol take its place in inflammatory bowel disease surgeryECCO'24Year: 2024
Authors: Barugola, G.(1);Bertocchi, E.(1);Masini, G.(1);Geccherle, A.(2);Variola, A.(2);Todeschini, A.(3)*;
(1)IRCCS Sacro Cuore Don Calabria, General Surgery, Negrar di Valpolicella, Italy;(2)IRCCS Sacro Cuore Don Calabria, IBD Unit, Negrar di Valpolicella, Italy;(3)IRCCS Sacro Cuore Don Calabria, IBD Unit, Negrar di Valpolicella, Italy;
P533: Photo Biomodulation treatment in patients with Ulcerative ColitisECCO'24Year: 2024
Authors: Weisshof, R.(1)*;Naftali, T.(2);Waterman, M.(1);Godneva, A.(3);Koifman, E.(4);Stein, A.(2);Segal, E.(3);Chowers, Y.(4);
(1)Rambam Health Care Campus, Department of Gastroenterology, Haifa, Israel;(2)Meir Hospital, Institute of Gastroenterology, Kfar Saba, Israel;(3)Weizmann Institute of Science, Department of Computer Science and Applied Mathematics, Rehovot, Israel;(4)Rambam Health Care Campus, Department of Gastroenterology-, Haifa, Israel;
P535: Effectiveness of upadacitinib in patients with Ulcerative Colitis: a real-life, multicenter, Italian reportECCO'24Year: 2024
Authors: Teani, I.(1)*;Bevilacqua, N.(1);Gabbiadini, R.(2);Bezzio, C.(3);Ferronato, A.(4);Saibeni, S.(3);Armuzzi, A.(2);Comberlato, M.(1);Desideri, F.(1);
(1)San Maurizio Hospital, Gastroenterology Department, Bolzano, Italy;(2)Humanitas Research Hospital-IRCCS, IBD Center, Milano, Italy;(3)Rho Hospital- ASST Rhodense, Gastroenterology Unit, Milano, Italy;(4)Santorso Hospital- AULSS 7, Digestive Endoscopy, Vicenza, Italy;
P536: Outcome of colorectal cancer surveillance in paediatric inflammatory bowel disease: Time for new guidelines?ECCO'24Year: 2024
Authors: Vermeer, E.(1,2,3)*;Palsma, C.J.(1);Gorter, R.R.(4);de Boer, N.K.(2,5);de Jonge, R.(6);Roelofs, J.J.(7);de Meij, T.G.J.(1,2,3);
(1)Amsterdam UMC, Paediatric Gastroenterology, Amsterdam, The Netherlands;(2)Amsterdam UMC, Amsterdam Gastroenterology- Endocrinology and Metabolism Research Institute, Amsterdam, The Netherlands;(3)Amsterdam UMC, Amsterdam Reproduction and Development Research Institute, Amsterdam, The Netherlands;(4)Amsterdam UMC, Paediatric Surgery, Amsterdam, The Netherlands;(5)Amsterdam UMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(6)Amsterdam UMC, Laboratory Medicine, Amsterdam, The Netherlands;(7)Amsterdam UMC, Pathology, Amsterdam, The Netherlands;
P537: Analysis of immunological VAriables in ex vivo Tofacitinib-treated human biopsies from Active ulcerative colitis patients to predict clinical Response (the AVATAR study)ECCO'24Year: 2024
Authors: Onali, S.(1);Di Petrillo, A.(2);Soddu, P.(2);Ibba, I.(3);Demurtas, M.(3);Raho, N.(2);Morrocchi, E.(4);Amodio, D.(4);Palma, P.(4);Milenkovic, S.(5);Ceccarelli, M.(5);FantiniMD- PhD, M.C.(6)*;
(1)University of Cagliari, Department of Medical Science and Public Health, Rome, Italy;(2)University of Cagliari, Department of Medical Science and Public Health, Cagliari, Italy;(3)University Hospital of Cagliari, Gastroenterology Unit, Cagliari, Italy;(4)University of Rome Tor Vergata, Department of Systems Medicine, Rome, Italy;(5)University of Cagliari, Department of Physics, Cagliari, Italy;(6)University of Cagliari, of Medical Science and Public Health, Monserrato, Italy;
P538: Platelet-rich stroma during surgery for treatment-refractory perianal fistulizing Crohn’s disease: long-term outcomes of a pilot studyECCO'24Year: 2024
Authors: Bak, M.(1)*;Witjes, C.(2);Arkenbosch, J.(3);Dwarkasing, R.(4);van Dongen, J.(5);Fuhler, G.(3);Schouten, R.(6);van der Woude, J.(3);de Vries, A.(3);van Ruler, O.(7);
(1)Erasmus University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(2)IJsselland Hospital, Department of Surgery, Cappelle aan den IJssel, The Netherlands;(3)Erasmus University Medical Center Rotterdam, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(4)Erasmus University Medical Center Rotterdam, Radiology, Rotterdam, The Netherlands;(5)University Medical Center Utrecht, Department of Plastic- Reconstructive and Hand Surgery, Utrecht, The Netherlands;(6)IJsselland Hospital, Department of Surgery, Capelle aan den IJssel, The Netherlands;(7)IJselland Hospital, Department of Surgery, Capelle aan den IJssel, The Netherlands;
P539: Assessment of VEdolizumab aNd Ustekinumab in Elderly patients with Crohn’s disease (CD): the IG-IBD AVENUE study.ECCO'24Year: 2024
Authors: Viola, A.(1);Ventimiglia, M.(2);Sparacino, A.(3);Orlando, A.(4);D@E@Antono, E.(4);De Vivo , S.(4);Scaldaferri, F.(5);Pugliese, D.(5);Varca, S.(6);Ribaldone, D.G.(7);Armandi, A.(7);Balestrieri , P.(8);Castiglione, F.(9);Savarino, E.V.(10);Cappello, M.(11);Viganò, C.(12);Mocci, G.(13);Allocca, M.(14);Principi, M.B.(15);Soriano, A.(16);Onali, S.(17);Bodini, G.(18);Riguccio, G.(19);Festa, S.(20);Bertani, L.(21);Checchin, D.(22);Caprioli, F.A.(23);Fries, W.(24)*;
(1)IBD-Unit- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy;(2)Directorate General of Medical Devices and Pharmaceutical service, Italian Ministry of Health-, Milan, Italy;(3)IBD-Unit- Department of Clinical and Experimental Medicine- University of Messina. Head IBD Clinic- Gastroenterology Section- Promise, University of Palermo, Palermo, Italy;(4)Riuniti Villa Sofia–Cervello Hospital, IBD Unit Palermo, Palermo, Italy;(5)CEMAD - IBD UNIT- Dipartimento di Scienze Mediche e Chirurgiche- Fondazione Policlinico Universitario Gemelli- IRCCS- Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Roma, Italy;(6)CEMAD - IBD UNIT- Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario Gemelli- IRCCS, Roma, Italy;(7)Division of Gastroenterology- Department of Medical Sciences, University of Turin, Torino, Italy;(8)Unit of Gastroenterology, Campus Bio-Medico University, Roma, Italy;(9)Gastroenterology- Department of Clinical Medicine and Surgery, University Federico II of Naples, Napoli, Italy;(10)Department of Surgery- Oncology and Gastroenterology, University of Padova, Padova, Italy;(11)Head IBD Clinic- Gastroenterology Section- Promise, University of Palermo, Palermo, Italy;(12)Department of Gastroenterology- and Center for Autoimmune Liver Diseases- European Reference Network on Hepatological Diseases ERN RARE-LIVER- Fondazione IRCCS San Gerardo dei Tintori, University of Milano-Bicocca School of Medicine, Monza, Italy;(13)Gastroenterologia, ARNAS G. Brotzu, Cagliari, Italy;(14)IRCCS OSPEDALE San Raffaele- Gastroenterology and Endoscopy, IBD Center, Milano, Italy;(15)Gastroenterology Unit Department of Precision and Regenerative Medicine and Ionian Area DiMePRe-J., University of Bari, Bari, Italy;(16)IBD Center- Internal Medicine Department- Arcispedale S. Maria Nuova, IRCCS Reggio Emilia, Reggio Emilia, Italy;(17)Dept of Medical Science and Public Health- Gastroenterology Unit, University of Cagliari, Cagliari, Italy;(18)IRCCS Policlinico San martino- Gastrointestinal Unit- Department of Internal Medicine, University of Genoa, Genova, Italy;(19)UOSD Malattie Infiammatorie Croniche intestinali, Ospedale Santa Maria del Prato, Feltre, Italy;(20)IBD Unit, @D@San Filippo Neri@D@ Hospital, Roma, Italy;(21)Tuscany North West ASL- Pontedera Hospital, Dept of General Surgery and Gastroenterology, Pontedra, Italy;(22)Gastrointestinal Unit, Ospedale dell@E@Angelo, Venezia, Italy;(23)Gastroenterology and Endoscopy Unit- Fondazione IRCCS Cà Granda- Ospedale Maggiore Policlinico, Department of Pathophysiology and Transplantation- University of Milan, Milano, Italy;(24)IBD-Unit- Dept of Clinical and Experimental Medicine, University of Messina, Messina, Italy;AVENUE Study Group: Michele Francesco Chiappetta Giulio Calabrese Piera Melatti Giorgia Orrù Francesca Maria Onidi Giorgia Orrù Maria Napolitano Francesca Onnis
P540: Non-serious adverse events in patients with ulcerative colitis receiving etrasimod: An analysis of the phase 2 OASIS and phase 3 ELEVATE UC 52 and ELEVATE UC 12 clinical trialsECCO'24Year: 2024
Authors: Lees, C.(1,2)*;Torres, J.(3,4,5);Leung, Y.(6);Vermeire, S.(7);Fellmann, M.(8);Modesto, I.(9);McDonnell, A.(10);Lazin, K.(8);Keating, M.(9);Goetsch, M.(8);Wu, J.(11);Loftus Jr, E.V.(12);
(1)University of Edinburgh, Institute of Genetics & Molecular Medicine, Edinburgh, United Kingdom;(2)Western General Hospital- NHS Lothian, Edinburgh IBD Unit, Edinburgh, United Kingdom;(3)Hospital Beatriz Ângelo, Division of Gastroenterology, Loures, Portugal;(4)., Faculdade de Medicina- Universidade de Lisboa, Lisbon, Portugal;(5)Hospital da Luz, Division of Gastroenterology, Lisbon, Portugal;(6)University of British Columbia, Department of Medicine- Department of Gastroenterology, Vancouver- BC, Canada;(7)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(8)., Pfizer AG, Zürich, Switzerland;(9)., Pfizer Inc, New York- NY, United States;(10)., Pfizer Ltd, Sandwich, United Kingdom;(11)., Pfizer Inc, Cambridge- MA, United States;(12)Mayo Clinic College of Medicine and Science, Division of Gastroenterology and Hepatology, Rochester- MN, United States;
